Accepted answer
99.4 and 98.2 are 1.2 percentage points apart, which sounds small until you restate it as impurity. PeptideMeter is leaving 0.6 per cent of the detected area unassigned and Janoshik 1.8 per cent — a factor of 3 between them. The impurity fraction is the quantity that moves when a method changes, and it is the one worth arguing about; the headline is just its complement. Comparable means same column chemistry, same gradient slope, same detection wavelength, same integration convention. Until you have those four from both laboratories, 99.4 and 98.2 are two measurements of slightly different quantities that happen to share a unit.
Read the chromatogram before you read the number, because the number without the trace is not a measurement, it is a claim.
Tailing factor measures peak shape, and a badly tailing peak spreads into the region where small impurities live, forcing tangent-skim integration that assigns tail area to the main peak.
Buffer versus acid in the mobile phase changes the ionisation state of basic and acidic residues, shifting retention and selectivity — same vial, potentially different separation.
Published side-by-side method comparisons show that a two-point difference in purity on the same vial is easily explained by method choice alone.
Worth noting that method standardisation is poor in the research-grade space compared to pharmaceutical work, so identical-looking methods can produce different results.
If you are ranking vendors, specify a method and have all samples tested at the same place.
edited 8 Nov 2025 by b_delacroix — added the placebo-arm figures
3The distinction between purity and content cannot be repeated often enough here. – tobias_maartens 5 months ago add a comment